ESPR
ESPR
NASDAQ · Pharmaceuticals

Esperion Therapeutics Inc

$3.18
-0.01 (-0.31%)
As of Aug 8, 1:47 AM ET ·
Analyst Consensus
Sell
11
Analysts
Moderate
Coverage
Buy 0 0%
Hold 8 73%
Sell 3 27%
Price Target
Analyst Price Target +494.7% upside
Low Target $12.50
Average Target $18.91
High Target $21.23
Current Price $3.18
Current
$3.18
Target
$18.91
$12.50 $18.91 avg $21.23
Scenario Analysis
Bear Case
$12.50
293.1%
Low target
Base Case
$18.91
+494.7%
Avg target
Bull Case
$21.23
+567.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.18
-23.9% from high
52-Week Low
$1.38
+130.4% from low
Target vs 52W High
$18.91
+352.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%